HUTCHMED (China) Ltd (HCM) › Cash & EquivalentsHUTCHMED (China) Ltd (HCM) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2013: $46.86M2014: $38.95M2015: $31.94M2016: $79.43M2017: $85.27M2018: $86.04M2019: $121.16M2020: $235.63M2021: $377.54M2022: $313.28M2023: $283.59M2024: $153.96M2025: $71.33M$71.33M2013Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$71.33M-53.7%2024$153.96M-45.7%2023$283.59M-9.5%2022$313.28M-17.0%2021$377.54M+60.2%2020$235.63M+94.5%2019$121.16M+40.8%2018$86.04M+0.9%2017$85.27M+7.3%2016$79.43M+148.7%2015$31.94M-18.0%2014$38.95M-16.9%2013$46.86M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share